Table 1.
Progress in the role of circRNA in IBD and its associated CRC
| circRNA | Regulation trend in IBD or CRC | Mechanism and Function | Clinical significance | Reference |
|---|---|---|---|---|
| circ_103516 | Upregulated in IBD | Dysregulation of circRNA_103516 may participate in the molecular mechanism of IBD through hsa-miR-19b-1-5p sponging, which shows a positive correlation with disease activity and inflammatory cytokines such as TNF-α and IFN-γ. | A novel biomarker of IBD diagnosis. | [77] |
| circ_0007919 | Downregulated in UC | Enhances the expression levels of EPC1 and VIPR1 by sponging let-7a and miR-138; related to clinical characteristics and epithelial integrity. | Potential diagnostic and therapeutic implications. | [73] |
| circ_004662 | Upregulated in IBD | Correlated with mammalian target of rapamycin (mTOR) pathway which involved in the inflammation and activation of intestinal T cells. | Preferable diagnostic biomarker of CD and novel candidate for differentiating CD from UC. | [74] |
| CDKN2B-AS1 | Downregulated in IBD | Exhibites inhibitory effects in colonic epithelial cell proliferation by interacting with claudin-2 that can decrease barrier function. | A novel lncRNA affecting UC biology. | [80] |
| circ_102610 | Upregulated in CD | Promote the proliferation and EMT of intestinal epithelial cells via sponging of miR-130a-3p, trigger intestinal fibrosis accompanying CD. | Serve as a potential target for CD therapy and novel drug research. | [82] |
| circPACRGL | Upregulated in CRC | Enhances the proliferation, migration and invasion of CRC cells, as well as the differentiation of N1 and N2 granulocytosis through miR-142-3p/miR-506-3p-TGF-β1 axis. | Promoting role in the course of CRC. | [83] |
| circ_0000069 | Upregulated in CRC | Promote the expression of cancer cells and improve the survival rate, apoptosis rate and invasiveness of CAC cells. | Potential diagnostic markers. | [86-88] |
| circ_0020397 | ||||
| circ_001569 | ||||
| circ_0004585 | Upregulated in CRC | Positively correlated with tumor size. | Potential diagnostic marker. | [89] |
| circ_0001178 | Upregulated in CRC | Not available. | Used as potential biomarkers for liver metastasis of CRC. | [90] |
| circ_0000826 | ||||
| circDDX17 | Downregulated in CRC | Potentially binds to miR-21-5p, and participates in the KEGG pathways of CRC. | Tumor suppressor and a therapeutic target for CRC. | [75] |
| circ_103809 | Downregulated in CRC | Related to the metastasis, differentiation, and perineural infiltration of CRC. | Potential diagnostic and prognostic marker. | [91] |
| circ_104700 | ||||
| circBANP | Upregulated in CRC | Knockdown of circBANP with siRNA significantly attenuate the proliferation of CRC cells. | Serve as a prognostic and therapeutic marker. | [93] |
| CCDC66 | Upregulated in CRC | Controls cell proliferation, migration and anchorage-independent growth. | Negatively correlated with poor prognosis. | [85] |
| circ_102958 | Upregulated in CRC | Promote the proliferation, migration and invasion of CRC cells through circRNA_102958/miR-585/CDC25B axis. | Potential prognostic marker. | [94] |